Back to DE D. E. Shaw & Co., Inc.

CORTCORT

Showing 8 of 31 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in Corcept Therapeutics Incorporated.

Yes. D. E. Shaw holds 883,001 shares of CORT (Corcept Therapeutics), worth $76.8M, as of its Q2 2026 13F filing. It reduced the position by 298,347 shares (-25.3%) from Q1 2026. D. E. Shaw has held CORT in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$76.8M

Current Shares

883,001

Total Value Change

+$40.3M

Total Shares Change

+94,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
883,001
-25.3%
$76.8M0.0%$86.95
0
2026-Q1
Increased
1.2M
+596.3%
$47.6M0.0%$40.31
47
2025-Q4
Decreased
169,667
-71.0%
$5.9M0.0%$34.80
0
2025-Q3
Decreased
584,098
-13.2%
$48.5M0.0%$83.11
0
2025-Q2
Decreased
673,137
-3.9%
$49.4M0.0%$73.40
0
2025-Q1
Decreased
700,264
-21.0%
$80M0.1%$114.22
0
2024-Q4
Increased
886,576
+12.5%
$44.7M0.0%$50.39
33
2024-Q3
Decreased
788,064
-17.0%
$36.5M0.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used